about
A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusionFuroxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.Density functional theory (DFT) study of edaravone derivatives as antioxidants.Chemometric QSAR modeling and in silico design of antioxidant NO donor phenols.Microwave assisted synthesis of novel pyrazolone derivatives attached to a pyrimidine moiety and evaluation of their anti-inflammatory, analgesic and antipyretic activities.NO and HNO donors, nitrones, and nitroxides: Past, present, and future.
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Edaravone derivatives containing NO-donor functions.
@en
Edaravone derivatives containing NO-donor functions.
@nl
type
label
Edaravone derivatives containing NO-donor functions.
@en
Edaravone derivatives containing NO-donor functions.
@nl
prefLabel
Edaravone derivatives containing NO-donor functions.
@en
Edaravone derivatives containing NO-donor functions.
@nl
P2093
P50
P356
P1476
Edaravone derivatives containing NO-donor functions.
@en
P2093
Alberto Gasco
Clara Cena
Marta Giorgis
P304
P356
10.1021/JM8007008
P407
P50
P577
2009-01-01T00:00:00Z